Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| OTHER | HLA class II histocompatibility antigen, DRB1-15 beta chain other |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Lymphoma | 1 | D008223 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL2109447 |
CONTENTS